Mangalam Drugs & Organics Limited MANGALAM.NS Stock
Mangalam Drugs & Organics Limited Price Chart
Mangalam Drugs & Organics Limited MANGALAM.NS Financial and Trading Overview
| Mangalam Drugs & Organics Limited stock price | 102.15 INR |
| Previous Close | 112.05 INR |
| Open | 112.7 INR |
| Bid | 110.5 INR x 0 |
| Ask | 110.85 INR x 0 |
| Day's Range | 110.1 - 112.7 INR |
| 52 Week Range | 95.25 - 173 INR |
| Volume | 62.11K INR |
| Avg. Volume | 46.24K INR |
| Market Cap | 1.75B INR |
| Beta (5Y Monthly) | 0.679794 |
| PE Ratio (TTM) | 138.0625 |
| EPS (TTM) | -7.16 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | December 21, 2017 |
| 1y Target Est | N/A |
MANGALAM.NS Valuation Measures
| Enterprise Value | 2.52B INR |
| Trailing P/E | 138.0625 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.47224376 |
| Price/Book (mrq) | 1.1507605 |
| Enterprise Value/Revenue | 0.68 |
| Enterprise Value/EBITDA | 9.863 |
Trading Information
Mangalam Drugs & Organics Limited Stock Price History
| Beta (5Y Monthly) | 0.679794 |
| 52-Week Change | -21.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 173 INR |
| 52 Week Low | 95.25 INR |
| 50-Day Moving Average | 109.85 INR |
| 200-Day Moving Average | 125.34 INR |
MANGALAM.NS Share Statistics
| Avg. Volume (3 month) | 46.24K INR |
| Avg. Daily Volume (10-Days) | 67.97K INR |
| Shares Outstanding | 15.83M |
| Float | 6.58M |
| Short Ratio | N/A |
| % Held by Insiders | 51.73% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0.34% |
| Operating Margin (ttm) | 3.92% |
| Gross Margin | 32.29% |
| EBITDA Margin | 6.89% |
Management Effectiveness
| Return on Assets (ttm) | 2.63% |
| Return on Equity (ttm) | 0.83% |
Income Statement
| Revenue (ttm) | 3.7B INR |
| Revenue Per Share (ttm) | 233.19 INR |
| Quarterly Revenue Growth (yoy) | -24.69% |
| Gross Profit (ttm) | 1.22B INR |
| EBITDA | 255.18M INR |
| Net Income Avi to Common (ttm) | 12.7M INR |
| Diluted EPS (ttm) | 0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.88M INR |
| Total Cash Per Share (mrq) | 1.7 INR |
| Total Debt (mrq) | 885.47M INR |
| Total Debt/Equity (mrq) | 58.27 INR |
| Current Ratio (mrq) | 1.249 |
| Book Value Per Share (mrq) | 95.98 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 395.23M INR |
| Levered Free Cash Flow (ttm) | -94078248 INR |
Profile of Mangalam Drugs & Organics Limited
| Country | India |
| State | N/A |
| City | Mumbai |
| Address | Rupam Building |
| ZIP | 400001 |
| Phone | 91 22 2261 6200 |
| Website | https://www.mangalamdrugs.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Mangalam Drugs & Organics Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates at VAPI in India and internationally. It offers a range of API products, which include Acyclovir, Amodiaquine, Artemether, Artesunate, Atorvastatin Calcium, Atazanavir Sulfate, Bisoprolol Fumarate, Chloroquine Phosphate, and Dolutegravir Sodium; Efavirenz, Emtricitabine, Furosemide, Hydroxychloroquine Sulphate, Lumefantrine, and Nimesulide; Nitrofurantoin Anhydrous and Monohydrate; Primaquine and Piperaquine Phosphate; Pregabalin, Pyrimethamine, Pyronaridine Tetraphosphate, and Sulfadoxine; and Tenofovir Alafenamide Hemifumarate and Disoproxil Fumarate. The company also offers intermediates comprising 2-Dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-Dichloro-5-methoxy pyrimidine; 4,7 Dichloroquinoline; Ortho phenoxy methane sulfonanilide; and Tenofovir Alafenamide Base and Disoproxil Base. In addition, it offers specialty chemicals, such as Menthol; 2,3-Dihydrophthalazine-1, 4-dione; and 4-cynoethyl-2-methyl phenol. The company was incorporated in 1972 and is based in Mumbai, India.
Q&A For Mangalam Drugs & Organics Limited Stock
What is a current MANGALAM.NS stock price?
Mangalam Drugs & Organics Limited MANGALAM.NS stock price today per share is 102.15 INR.
How to purchase Mangalam Drugs & Organics Limited stock?
You can buy MANGALAM.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mangalam Drugs & Organics Limited?
The stock symbol or ticker of Mangalam Drugs & Organics Limited is MANGALAM.NS.
Which industry does the Mangalam Drugs & Organics Limited company belong to?
The Mangalam Drugs & Organics Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Mangalam Drugs & Organics Limited have in circulation?
The max supply of Mangalam Drugs & Organics Limited shares is 15.87M.
What is Mangalam Drugs & Organics Limited Price to Earnings Ratio (PE Ratio)?
Mangalam Drugs & Organics Limited PE Ratio is now.
What was Mangalam Drugs & Organics Limited earnings per share over the trailing 12 months (TTM)?
Mangalam Drugs & Organics Limited EPS is -7.16 INR over the trailing 12 months.
Which sector does the Mangalam Drugs & Organics Limited company belong to?
The Mangalam Drugs & Organics Limited sector is Healthcare.